Amazingly inspirational oration by Dr Advani at the TMH Medical Oncology Alumni meet this evening. Tata Memorial Hospital

Congratulations to all the Alumni and the faculties.

Congratulations Dr.Santhosh kumar Devadas for 💯 stem cell transplant at your centre.

Our first CD19 CAR T product patent granted for next 20years. It will help make much cell & gene therapy affordable & accessible to many and put India on the map of innovation in bio-medicine. Huge congratulations to Dr Rahul Purwar & team. #cartcelltherapy #iitbombay #biotech

Extremely happy to share that we will be initiating clinical services (OPDs, Minor OT, Chemotherapy day care, Radiotherapy, X-ray, ultrasound, CT scan, MRI, Laboratory services - Pathology, Biochemistry and Microbiology) on May 3rd,2022 at HBCH&RC,Medicity, New Chandigarh,Punjab

Join our virtual MD Anderson Cancer Center Emil J Freireich Hematology Grand Rounds “CAR-T Cell Therapy for Acute Lymphoblastic Leukemia” presented by Dr. Nitin Jain, Nitin Jain | May 4, 2022 8 am CST | mdanderson.org/research/depar… | #leusm #MedEd

We need level 1 evidence before adopting robotics. If only we were willing to wait. Negative results of ORATOR 2. ACTREC-TMC TMH Medical Oncology Alumni Cancer Research, Statistics and Treatment Atul Sharma Bharat Amol Patel ja.ma/3L0LIcX via JAMA Oncology part of JAMA Network

NGS-based MRD (sensitivity: 1x10^-6) is superior to flow MRD in predicting ALL relapse. Rapid NGS MRD negativity should be the goal of any new #ALL therapy. Nicholas Short, MD, Nicholas Short MD, of MD Anderson Cancer Center #Leukemia doi.org/10.1182/blooda… via Blood Advances #leusm

Remembering Dr E Donall Thomas today, the medical Oncologist who performed the first ever BMT and is known as the father of BMT. Medical Oncology and transplantation has progressed in leaps and bounds since then Let us learn what is medical Oncology 1/n Ranjit Kumar Sahoo Gaurav Prakash M.D.

Melodious voice of our Alumni. Dr Amol Akhade Sujith Dr Rajesh Bollam - Cancer Specialist in Hyderabad akhilrk1989 Dr Akhil Kapoor Lingaraj Nayak

Our experience on the management of 56 pts with small cell cancer of the esophagus. Two take home points: Very few CNS relapses. Survival was very poor- even in limited stage disease. OncoAlert Tata Memorial Hospital TMH Medical Oncology Alumni

Results of addition of low dose Nivolumab to Palliative Chemotherapy in HNSCC phase 3 study #ASCO22 Vanita Noronha, MBBS MD DM Pan Pantziarka Head and Neck Cancer International Group Sewanti Limaye 🇮🇳🇺🇸 Dr Amol Akhade Ashish Singh meetings.asco.org/abstracts-pres…

HNSCC for CTRT and Cisplatin ineligible🤔? #asco2022. Our study on Cisplatin unfit might help. Join HN oral session on 3rd June 2022. Head and Neck Cancer International Group Prof. Anil D'Cruz Vanita Noronha, MBBS MD DM Bharat Dr Manuprasad Dr Amol Akhade Atul Sharma TMH Medical Oncology Alumni @EORTC_HNCG_YI

This is Gold Mine of Information on how to analyze clinical trials and try to figure out the hidden truth behind what that is printed and how not to get influenced by what is being promoted. Must to read thread for all Young Oncologists Group India🇮🇳 TMH Medical Oncology Alumni Young Oncologists Group India🇮🇳

How NOT to Present . Young Oncologists Group India🇮🇳 TMH Medical Oncology Alumni

Congratulations. #ASCO22 #LMIC Metronomics/low dose IO/Elderly unfit.... LMIC issues and solutions.